GLP1 News and Research

RSS
Redpoint Bio decreases third quarter net loss to $1.8 million

Redpoint Bio decreases third quarter net loss to $1.8 million

TransPharma Medical completes ViaDerm-GLP1 agonist Phase 1a trial for type II diabetes

TransPharma Medical completes ViaDerm-GLP1 agonist Phase 1a trial for type II diabetes

Redpoint Bio issued patent that covers high-throughput screening technology

Redpoint Bio issued patent that covers high-throughput screening technology

Redpoint Bio announces revenue of $1.9M for full-year 2009

Redpoint Bio announces revenue of $1.9M for full-year 2009

How and why weight-reducing surgery sometimes cures diabetes

How and why weight-reducing surgery sometimes cures diabetes

Pine nut oil boosts appetite suppressors

Pine nut oil boosts appetite suppressors

Severe hypoglycemia - complication of gastric bypass surgery

Severe hypoglycemia - complication of gastric bypass surgery